iwNHL 2015 | Therapeutic opportunities for lenalidomide in non-Hodgkin lymphoma

Name: Therapeutic opportunities for lenalidomide in non-Hodgkin lymphoma
Uploaded: 2015-10-03T00:00:00.000Z
Duration: 3 min 12 s
Description: At the International Workshop on Non-Hodgkin Lymphoma (iwNHL) 2015 meeting, Nathan H. Fowler, MD, of The University of Texas MD Anderson Cancer Center, Houston, TX, discusses the ongoing clinical trials that are investigating the use of lenalidomide, an immunomodulatory drug, as monotherapy or in combination for the treatment of different subtypes of non-Hodgkin lymphoma.

Nathan Fowler • 3 Oct 2015

iwNHL 2015

Non-Hodgkin Lymphoma Lenalidomide

At the International Workshop on Non-Hodgkin Lymphoma (iwNHL) 2015 meeting, Nathan H. Fowler, MD, of The University of Texas MD Anderson Cancer Center, Houston, TX, discusses the ongoing clinical trials that are investigating the use of lenalidomide, an immunomodulatory drug, as monotherapy or in combination for the treatment of different subtypes of non-Hodgkin lymphoma.